On 2/18/2011 7:04 PM, Mark Roberts wrote:
This Monday past I had a meeting at Dana-Farber with Dr. Carlos
Rodriguez-Galindo, the oncologist who's heading this program. He
described their plans and where they stand now. He's very interested
in getting our support because they're really just getting started -
we'd be getting in on the ground floor with this effort. That has some
disadvantages as far as name recognition, but I think that being under
the Dana-Farber umbrella will make up for that to a significant
degree.

Another advantage is that this organization is headquartered here in
Boston, about two miles from my house. They won't be able to ignore
emails from me like CureSearch because they know I can be right there
in their faces at a moment's notice. The link with Dana-Farber also
gets instant cred around these parts, which I hope will be beneficial
when I start hitting the local media about the 2011 book in a few
weeks.

Any thoughts?


Mark, my only concern would be that the money we donate reach the ultimate target. What you say seems to fully confirm this. So, my answer is - you chose wisely. If at any time it happens to be disappointing, we can still reconsider.

Boris


--
PDML Pentax-Discuss Mail List
[email protected]
http://pdml.net/mailman/listinfo/pdml_pdml.net
to UNSUBSCRIBE from the PDML, please visit the link directly above and follow 
the directions.

Reply via email to